Quantifying adverse drug events : are systematic reviews the answer?

Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Mahyar EtminanPaula A Rochon

Abstract

Quantifying adverse drug events (ADEs) is critical to clinicians, consumers and policy makers. Most ADE information comes from large clinical trials. Systematic reviews have become a popular tool in quantifying the efficacy of different therapeutic interventions and ADE data collected in randomised trials may be helpful in quantifying the risk associated with a specific pharmacological agent. However, clinicians who are interested in conducting systematic reviews of ADEs may face many challenges. These challenges are geared towards two main areas: poor quality of ADE reporting in randomised trials and poor indexing of ADEs in medical databases. In this review, we will discuss these challenges in detail using some examples from the literature. Where possible, we also discuss strategies that may overcome these problems. More rigourous standards of reporting ADEs in randomised trials, as well as better indexing of ADE terminology in medical databases, could one day make systematic reviews of ADEs a powerful tool for practising clinicians.

References

Jan 22, 1996·Archives of Internal Medicine·J P IoannidisH S Sacks
Mar 1, 1997·Annals of Internal Medicine·D J CookR B Haynes
Jan 24, 1998·Lancet·J LauC H Schmid
Mar 10, 1999·JAMA : the Journal of the American Medical Association·J A Berlin, G A Colditz
Oct 28, 1999·PharmacoEconomics·T J WhiteJ P Rho
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Aug 6, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·S J FruchtS Fahn
Jan 9, 2001·Archives of Internal Medicine·E Ernst, M H Pittler
Mar 10, 2001·JAMA : the Journal of the American Medical Association·J P Ioannidis, J Lau
Apr 20, 2001·JAMA : the Journal of the American Medical Association·D MoherUNKNOWN CONSORT Group (Consolidated Standards for Reporting of Trials)
Oct 23, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M EtminanP A Rochon
May 30, 2002·The American Journal of Medicine·Mahyar EtminanPaula A Rochon
Sep 11, 2002·Journal of General Internal Medicine·David BlackburnMuhammad Mamdani
Dec 31, 2002·JAMA : the Journal of the American Medical Association·Erling TronvikGunnar Bovim
May 3, 2003·Lancet·Derrick A Bennett, Andrew Jull

❮ Previous
Next ❯

Citations

Oct 28, 2010·Diabetes, Obesity & Metabolism·G Schernthaner, R J Chilton
Feb 10, 2006·Health Information and Libraries Journal·Su GolderUNKNOWN Centre for Reviews and Dissemination and UK Cochrane Centre Search Filters Design Group
May 1, 2009·Journal of the Medical Library Association : JMLA·Su Golder, Yoon Loke
Feb 10, 2006·Pharmacotherapy·Jennifer J G SteffensmeierArthur J Hartz
Nov 29, 2016·European Journal of Haematology·Sebastian BotzenhardtAntje Neubert
Apr 21, 2006·The Cochrane Database of Systematic Reviews·C LeeC Gluud

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

BMC Medical Research Methodology
Yoon K LokeCochrane Adverse Effects Methods Group
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Jan P Vandenbroucke
The New England Journal of Medicine
Michael D Hughes, Paige L Williams
© 2021 Meta ULC. All rights reserved